Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | EP300 | Q09472 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL588080 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL588205 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL3181791 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL4755737 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL548489 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL4756812 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL413361 | 1.00 | — | — | |
| SCHEMBL4755732 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL4756755 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL167574 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1474 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024089310-A1 | BIODEGRADABLE IMINOSUGARS AND AMINO CYCLITOL GLYCOSIDES INHIBITING ALPHA-GLUCOSIDASE WITH SYNERGISTIC INSECTICIDE OR ACARICIDE ACTIVITY OR BOTH | FRANCISCO ARAGÓN S.L.U (ES) | 2024-05-02 | — | — | WO | claimed |
| US-20240026078-A1 | Polymer taking the form of a pulverulent solid and having properties for thickening polar media | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-01-25 | — | — | US | claimed |
| CN-117222690-A | Polymer in the form of a powdery solid and having the property of thickening polar medium | 化工产品开发公司SEPPIC | 2023-12-12 | — | — | CN | claimed |
| EP-4259693-A1 | POLYMER TAKING THE FORM OF A PULVERULENT SOLID AND HAVING PROPERTIES FOR THICKENING POLAR MEDIA | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2023-10-18 | — | — | EP | claimed |
| CN-111820417-B | Dried orange peel oil microcapsule and preparation method thereof | 广州绿萃生物科技有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-112481008-B | Production process of high-temperature-resistant precipitation antagonist | 山东恒利热载体工程技术有限公司 | 2022-06-28 | — | — | CN | claimed |
| WO-2022128452-A1 | POLYMER TAKING THE FORM OF A PULVERULENT SOLID AND HAVING PROPERTIES FOR THICKENING POLAR MEDIA | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2022-06-23 | — | — | WO | claimed |
| CN-113316473-A | Cosmetic O/W mascara composition comprising polyurethane resin | 布茨公司 | 2021-08-27 | — | — | CN | claimed |
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | DIC CORPORATION (JP) | 2021-08-03 | — | — | US | claimed |
| CN-112481008-A | High-temperature-resistant precipitation antagonist | 山东恒利热载体工程技术有限公司 | 2021-03-12 | — | — | CN | claimed |
| WO-1999023181-A1 | INK-JET INK COMPOSITIONS HAVING MAGNETIC PROPERTIES | HEWLETT-PACKARD COMPANY (US) | 1999-05-14 | — | — | WO | claimed |
| WO-1999023182-A1 | LATEX POLYMER BLENDS FOR INK-JET INKS | HEWLETT-PACKARD COMPANY (US) | 1999-05-14 | — | — | WO | claimed |
| WO-1999023183-A1 | PRINTING INK COMPOSITIONS HAVING SUPERIOR SMEAR-FASTNESS | HEWLETT-PACKARD COMPANY (US) | 1999-05-14 | — | — | WO | claimed |
| US-5288589-A | Storage stability | E.I. DU PONT DE NEMOURS AND COMPANY | 1994-02-22 | — | — | US | claimed |
| EP-0281360-B1 | HYDROPHOBICALLY MODIFIED NON-IONIC POLYGALACTOMANNAN ETHERS | STEIN, HALL & CO., INC. (US) | 1993-09-01 | — | — | EP | claimed |
| US-5179083-A | Coating composition containing as thickeners polygalactomannans modified with hydrophilic and hydrophobic groups | STEIN, HALL & CO., INC. (US) | 1993-01-12 | — | — | US | claimed |
| US-5167950-A | Antiseptics | S. C. JOHNSON & SON | 1992-12-01 | — | — | US | claimed |
| EP-0211550-B1 | COMPOSITION FOR PERSONAL CARE PRODUCTS COMPRISING ALKOXYLATED FATTY ALCOHOL AND POLYSILOXANE | DEUTSCHE ICI GMBH (DE) | 1991-04-10 | — | — | EP | claimed |
| US-4870167-A | THICKENERS FOR AQUEOUS SYSTEMS | HI-TEK POLYMERS, INC. (US) | 1989-09-26 | — | — | US | claimed |
| EP-0281360-A1 | Hydrophobically modified non-ionic polygalactomannan ethers | STEIN, HALL & CO., INC. (US) | 1988-09-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | EPB41, F12, CDK1 | TSHR 4803/4885THRB 4729/4885EP300 1481/4885 |
| US-20240026078-A1 | Polymer taking the form of a pulverulent solid and having properties for thickening polar media | PGAM1, GLUL, SGTA | TSHR 3936/4885THRB 4654/4885EP300 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.